** Analysts at E&P Capital say the balance sheet of
Australia's Ramsay Health Care RHC.AX is still somewhat
constrained on its ability to invest
** Say balance sheet constrains reflects continued earnings
pressure from offshore regions especially Europe
** Brokerage forecasts weaker margins in Australia relative
to pre-COVID on the back of higher employee costs with lower
efficiency
** See FY24 Australia EBIT margin of 9.7% compared to 15%
during pre-COVID itmes
** Brokerage has PT of A$50/share and 'negative' rating
** Three of 15 analysts rate the stock "buy", nine "hold"
and three "sell"; their median PT is A$53.50 – LSEG data
** Stock has fallen 3.6% this year, as of last close
(Reporting by Rishav Chatterjee in Bengaluru)
((Rishav.Chatterjee@thomsonreuters.com;))